Gillian Ryan, Lung Cancer Patient Advocate at White Ribbon for Lung Cancer, shared a post on LinkedIn:
“I’m incredibly proud to be a co-author on the PLAN study, bringing the patient perspective to this important research while working alongside Professor David O’Reilly. Ensuring the lived experience of people affected by lung cancer is included in research is something I care deeply about, and I’m honored to have contributed.”
Title: Clinical benefit and cost of plasma-first next-generation sequencing in patients with newly diagnosed advanced non-small cell lung cancer in Ireland: The PLAN study
Authors: David O’Reilly, Anthony O’Grady, Conor Hayes, Laura Piggott, Ruaidhri Keane, Orla M. Fitzpatrick, Michael Conroy, Nicholas Kruseman Aretz, David Synnott, Rachel Dillon, Gavin P. Dowling, Daniel J. Ryan, Emmet O’Brien, Ross Morgan, Oscar Breathnach, Liam Grogan, Patrick Morris, Megan Greally, Minh Yuen Teo, Adrian Murphy, Gillian Ryan, Ian Counihan, Cliona Ryan, Helen Barrett, Ann-Marie O’Shea, Sinead Cuffe, Grzegorz Korpanty, Lisa Prior, Martin P. Barr, Stephen Finn, Cathal O’Brien, Sarah McCarron, Rob Cummins, Sinead Toomey, Catríona M. Dowling, Siobhan Glavey, Bryan T. Hennessy, Jan Sorensen, Kathleen Bennett, Parthiban Nadarajan, Brendan Doyle, Jarushka Naidoo
Other articles featuring Gillian Ryan on OncoDaily.